Remove Compounding Remove Drug Development Remove Process Improvement
article thumbnail

Understanding Large Molecule Drug Development: From Biologics to Market

Syner-G

This shift from a linear to a network approach enhances the potential for one drug to target multiple sites. Structure-based drug design has evolved, facilitating the exploration of novel chemical probes and lead compound potency, and molecular docking utilizes target structures to predict interactions and offers simplicity and speed.

article thumbnail

The next frontier: Global leadership in biopharma

Express Pharma

Over the past few years, several emerging trends such as pricing and inflation, technology implementation, focus on sustainability practices, the transition toward personalised and next-generation therapeutics, and innovative healthcare delivery models, are compounding the complexities within manufacturing and supply chain operations.